Envista (NVST) Competitors $18.83 +0.19 (+1.02%) (As of 10/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NVST vs. SOLV, PEN, BLCO, GKOS, INSP, STVN, TMDX, PRCT, AXNX, and LIVNShould you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Penumbra (PEN), Bausch + Lomb (BLCO), Glaukos (GKOS), Inspire Medical Systems (INSP), Stevanato Group (STVN), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Axonics (AXNX), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. Envista vs. Solventum Penumbra Bausch + Lomb Glaukos Inspire Medical Systems Stevanato Group TransMedics Group PROCEPT BioRobotics Axonics LivaNova Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, media sentiment, risk, valuation and institutional ownership. Is SOLV or NVST more profitable? Solventum has a net margin of 0.00% compared to Envista's net margin of -52.25%. Envista's return on equity of 4.86% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Envista -52.25%4.86%3.00% Does the media favor SOLV or NVST? In the previous week, Solventum had 7 more articles in the media than Envista. MarketBeat recorded 10 mentions for Solventum and 3 mentions for Envista. Envista's average media sentiment score of 1.26 beat Solventum's score of 1.14 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, SOLV or NVST? Solventum has higher revenue and earnings than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.42N/AN/AN/AEnvista$2.53B1.28-$100.20M-$0.72-26.15 Do analysts recommend SOLV or NVST? Solventum presently has a consensus price target of $58.25, suggesting a potential downside of 14.01%. Envista has a consensus price target of $19.59, suggesting a potential upside of 4.04%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.88Envista 3 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in SOLV or NVST? Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 40.24% of users gave Envista an outperform vote while only 0.00% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform VotesNo VotesUnderperform Votes13100.00% EnvistaOutperform Votes3340.24% Underperform Votes4959.76% SummaryEnvista beats Solventum on 8 of the 12 factors compared between the two stocks. Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Get Envista News Delivered to You Automatically Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVST vs. The Competition Export to ExcelMetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$3.24B$4.30B$5.53B$19.35BDividend YieldN/A1.31%5.57%3.47%P/E Ratio-26.1523.26106.4327.17Price / Sales1.281.771,164.6318.69Price / Cash7.4913.2540.5220.75Price / Book0.771.244.935.19Net Income-$100.20M-$33.08M$116.97M$980.22M7 Day Performance-4.71%-1.84%3.06%0.25%1 Month Performance7.91%5.76%17.95%7.90%1 Year Performance-28.59%5.87%24.11%25.86% Envista Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVSTEnvista3.7563 of 5 stars$18.83+1.0%$19.59+4.0%-26.6%$3.24B$2.53B-26.1512,800Positive NewsGap UpSOLVSolventum1.7403 of 5 stars$67.40+0.2%$58.25-13.6%N/A$11.64B$8.25B0.0022,000Positive NewsPENPenumbra4.2803 of 5 stars$194.34-0.3%$208.00+7.0%-12.5%$7.55B$1.06B82.004,200Insider SellingBLCOBausch + Lomb3.2342 of 5 stars$18.92+0.2%$19.45+2.8%+10.9%$6.66B$4.50B-19.7113,300Analyst ForecastGKOSGlaukos3.8082 of 5 stars$131.37+3.6%$129.82-1.2%+87.1%$6.62B$341.73M-45.61780Positive NewsINSPInspire Medical Systems4.6913 of 5 stars$209.99+2.4%$216.62+3.2%+21.4%$6.24B$705.71M-381.801,011STVNStevanato Group2.6338 of 5 stars€19.15-2.6%N/A-39.3%$5.66B$1.09B34.825,635Gap UpTMDXTransMedics Group4.2655 of 5 stars$138.96-3.4%$174.30+25.4%+172.3%$4.58B$358.76M-408.71210Insider SellingNews CoveragePRCTPROCEPT BioRobotics1.9765 of 5 stars$73.23-1.5%$78.17+6.7%+143.0%$3.77B$176.58M-34.54430AXNXAxonics3.3106 of 5 stars$69.63flat$69.57-0.1%+23.7%$3.55B$408.81M-217.59610Insider SellingPositive NewsLIVNLivaNova4.3326 of 5 stars$54.00+1.5%$70.80+31.1%+4.1%$2.92B$1.21B-90.002,900Analyst ForecastPositive News Related Companies and Tools Related Companies: Solventum Alternatives Penumbra Alternatives Bausch + Lomb Alternatives Glaukos Alternatives Inspire Medical Systems Alternatives Stevanato Group Alternatives TransMedics Group Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives LivaNova Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVST) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.